Vertaling van "information between " (Nederlands → Frans) :

A concrete mechanism for coordinating the information flow between the FAMHP and these commissions, committees and working groups and the distribution of this information within the FAMHP is being devised.
A concrete mechanism for coordinating the information flow between the FAMHP and these commissions, committees and working groups and the distribution of this information within the FAMHP is being devised.

The SOE- USE’s first objectives are to train employees in their period of training and to develop an infrastructure that will make cooperation and the exchange of information between members possible.
The SOE- USE’s first objectives are to train employees in their period of training and to develop an infrastructure that will make cooperation and the exchange of information between members possible.

Due regard has been given to cooperation between the different services, the coordination of information flow, decision-making powers and hierarchical lines.
Due regard has been given to cooperation between the different services, the coordination of information flow, decision-making powers and hierarchical lines.

medicines for human use and veterinary medicines, raw materials (active ingredients) for pharmacists, establishment of retail pharmacies, medical devices) ●● Management of possible crisis situations ●● Coordination of the (inter)national representation of the FAMHP ●● The difference between the roles of “Communication” versus “Information” ●● Points of entry for applications submitted to
medicines for human use and veterinary medicines, raw materials (active ingredients) for pharmacists, establishment of retail pharmacies, medical devices) ●● Management of possible crisis situations ●● Coordination of the (inter)national representation of the FAMHP ●● The difference between the roles of “Communication” versus “Information” ●● Points of entry for applications submitted to

To minimise the risk of MRSA transmission by contacts with the patients and their families during transfer between healthcare facilities, it is recommended to provide clear information to the patients and their relatives about the significance of MRSA carriage and the precautions to be taken to limit its dissemination.
Afin de réduire au minimum le risque de transmission de MRSA par les contacts avec les patients ou leur famille au cours du transfert entre les installations des établissements de soins de santé, il est recommandé d’informer clairement le patient et sa famille de la signification du portage de MRSA et des précautions à prendre pour en limiter la dissémination.

In the first scenario, there is no significant difference between the respondents with regard to the choice of the place where the information is given (inside or outside the existing decision-making organs) according their current/past membership (or not) of the INAMI – RIZIV organs.
Only 26% would choose to inform the patient outside the existing organs, and with a stronger preference on informing after the decision is taken. In the first scenario, there is no significant difference between the respondents with regard to the choice of the place where the information is given (inside or outside the existing decision-making organs) according their current/past membership (or not) of the INAMI – RIZIV organs.

Bridging the gap between research and policy: Systematic reviews to inform policy and practice IT Bologna, 14-09-2012
Bridging the gap between research and policy: Systematic reviews to inform policy and practice IT Bologna, 14/09/2012

This release contains forward-looking information about a potential joint venture between Pfizer and Zhejiang Hisun Pharmaceuticals (Hisun) including, among other things, the anticipated benefits there of, that involves substantial risks and uncertainties.
This information contained in this release is as of June 2, 2011, Pfizer assumes no obligation to update forward-looking statements contaiTned in this release as the result of new information or future events or developments. This release contains forward-looking information about a potential joint venture between Pfizer and Zhejiang Hisun Pharmaceuticals (Hisun) including, among other things, the anticipated benefits there of, that involves substantial risks and uncertainties.